AR022621A1 - Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina - Google Patents

Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina

Info

Publication number
AR022621A1
AR022621A1 ARP000100678A ARP000100678A AR022621A1 AR 022621 A1 AR022621 A1 AR 022621A1 AR P000100678 A ARP000100678 A AR P000100678A AR P000100678 A ARP000100678 A AR P000100678A AR 022621 A1 AR022621 A1 AR 022621A1
Authority
AR
Argentina
Prior art keywords
treatment
deoxipeganine
nicotine dependence
pharmaceutical composition
composition containing
Prior art date
Application number
ARP000100678A
Other languages
English (en)
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR022621A1 publication Critical patent/AR022621A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP000100678A 1999-02-19 2000-02-17 Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina AR022621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906979A DE19906979B4 (de) 1999-02-19 1999-02-19 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
AR022621A1 true AR022621A1 (es) 2002-09-04

Family

ID=7898025

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100678A AR022621A1 (es) 1999-02-19 2000-02-17 Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina

Country Status (12)

Country Link
US (1) US6548510B1 (enExample)
EP (1) EP1150681B1 (enExample)
JP (1) JP4287596B2 (enExample)
KR (1) KR100681631B1 (enExample)
AR (1) AR022621A1 (enExample)
AT (1) ATE314850T1 (enExample)
AU (1) AU2670600A (enExample)
DE (2) DE19906979B4 (enExample)
DK (1) DK1150681T3 (enExample)
ES (1) ES2255977T3 (enExample)
PT (1) PT1150681E (enExample)
WO (1) WO2000048445A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DE10304141B4 (de) 2003-02-03 2006-03-09 Hf Arzneimittelforschung Gmbh Verfahren zur Herstellung von Chinazolin-Alkaloiden
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
EP1981518B1 (en) * 2006-07-11 2013-05-22 Adnan Jathlan Al-Rehaily Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent
RU2573293C2 (ru) 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking
CN104382964B (zh) * 2014-10-27 2017-07-28 上海中医药大学 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
US3987790A (en) 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4137300A (en) 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3843239C1 (enExample) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus

Also Published As

Publication number Publication date
DK1150681T3 (da) 2006-05-22
ATE314850T1 (de) 2006-02-15
JP2002537232A (ja) 2002-11-05
DE19906979A1 (de) 2000-08-31
KR20010102240A (ko) 2001-11-15
JP4287596B2 (ja) 2009-07-01
WO2000048445A3 (de) 2001-04-26
US6548510B1 (en) 2003-04-15
EP1150681A2 (de) 2001-11-07
EP1150681B1 (de) 2006-01-04
WO2000048445A2 (de) 2000-08-24
ES2255977T3 (es) 2006-07-16
PT1150681E (pt) 2006-05-31
DE19906979B4 (de) 2004-07-08
AU2670600A (en) 2000-09-04
DE50012014D1 (de) 2006-03-30
KR100681631B1 (ko) 2007-02-09

Similar Documents

Publication Publication Date Title
BR0107147A (pt) Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
AR004391A1 (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles.
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
GR1000380B (el) Μορφη δοσολογιας εχουσα μειωμενη πιθανοτητα καταχρησης.
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
AR033688A1 (es) Composicion parenteral reconstituible
AR025938A1 (es) Nuevas composiciones farmaceuticas.
AR018166A1 (es) Productos utilizables en el tratamiento de tumores, una composicion farmaceutica y el uso de una antraciclina sola o con un inhibidor de topoisomerasa iantineoplasico en la preparacion de medicamentos
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
CO4230093A1 (es) Derivados del indol y sus usos medicos
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.